Krzysztof Masternak

Leadership Team

Krzysztof Masternak, Director of Discovery

After obtaining a PhD in molecular virology at the University of Lausanne, Krzysztof worked for several year on gene expression regulation at the University of Geneva Medical School. He joined Novimmune in 2002, where he led several discovery programs to clinical ready stage.

As head of biology at Novimmune, Krzysztof was responsible for pioneering therapeutic CD47 dual targeting programs on the bispecific antibody platform.

Now as Director of Therapeutic Programs at Light Chain Bioscience, he drives the development of novel bispecific antibodies.

Back

First patient dosed with NILK-2301 in Phase I clinical trial

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer


Read more

LinkedIn